sefulness of postoperative probiotics in patients who underwent right hemicolectomy for colon cancer
- Conditions
- Neoplasms
- Registration Number
- KCT0005392
- Lead Sponsor
- The Catholic University of Korea, Uijeongbu St. Mary’s Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 40
? Adult men and women aged 20 to 80 years old
? Patients with colorectal cancer diagnosed histologically and imagingly, and who are scheduled for right colon resection
? Before the clinical trial begins, consent to participation in this clinical trial and sign a written consent.
? Those suffering from metastatic colon cancer
? Those who received chemotherapy or radiation therapy before surgery
? Patients with a history of severe cerebrovascular disease (cerebral infarction, cerebral hemorrhage, etc.), severe heart disease (unsafe angina, myocardial infarction, arrhythmia requiring heart failure treatment)
? Those with neurological or psychologically important medical history or currently suffering from a disease
? Those with a history of alcoholism or substance abuse
? People with immune system, infectious, gastrointestinal diseases (inflammatory bowel disease)
? Uncontrolled thyroid disease
? Creatinine is more than twice the normal upper limit of the test
? Those whose AST(GOT) and ALT(GPT) are more than 3 times the normal range
? Patients with uncontrolled hypertension (160/100mmHg or more, measured after 10 minutes of rest for the subject)
? Patients with uncontrolled diabetes (fasting blood sugar greater than 180mg/dl)
? Those who have taken or used probiotics or antibiotics within the last 1 week
? Pregnant women, lactating women, women of childbearing age who have a pregnancy plan or who do not agree with the selection of appropriate contraceptive methods
? Patients who have not performed the planned operation (right colon resection)
? Those who are judged to be inappropriate for this clinical trial
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Evaluation of bowel movements using the number of bowel movements per day and Bristol stool chart
- Secondary Outcome Measures
Name Time Method Cancer patient quality of life questionnaire (EORTC QLQ-C30)